NF-κB function in the human myometrium during pregnancy and parturition

Histology and Histopathology

Volumn 25, Issue 7, 2010, Pages 945-956

  Cookson, Victoria J ^a   Chapman, Neil R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Gene Regulation; Inflammation; NFkappaB; Parturition; Premature birth; Transcription

Indexed keywords

CYCLOOXYGENASE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; PTGS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BIRTH; CELL NUCLEUS; FEMALE; GENETICS; HUMAN; LABOR; METABOLISM; MYOMETRIUM; PHYSIOLOGY; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION;

CELL NUCLEUS; CYCLOOXYGENASE 2; DNA; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LABOR, OBSTETRIC; MYOMETRIUM; NF-KAPPA B; PARTURITION; PREGNANCY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956638047     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Allport V.C., Pieber D., Slater D.M., Newton R., White J.O. and Bennett P.R. (2001). Human labour is associated with nuclear factor-κB activity which mediates cyclo-oxygenase-2 expression and is involved with the "functional progesterone withdrawal". Mol. Hum. Reprod. 7, 581-586.
2. Arinze I.J. and Kawai Y. (2005). Transcriptional activation of the human Gasi2 gene promoter through Nuclear Factor-κB and antioxidant response elements. J. Biol. Chem. 280, 9786-9795.
3. Bailey J., Sparey C., Phillips R.J., Gilmore K., Robson S.C., Dunlop W. and Europe-Finner G.N. (2000). Expression of CREB, CREM and ATF2 cyclic AMP dependent transcription factors in the human myometrium during pregnancy and labour. Mol. Hum. Reprod. 6, 648-660.
4. Bailey J., Phillips R.J., Pollard A.J., Gilmore K, Robson S.C. and Europe-Finner G.N. (2002). Characterisation and functional analysis of CREM and ATF2 isoforms in the human myometrium during pregnancy and labour: identification of a novel ATF2 species with potent transactivation properties. J. Clin. Endocrinol. Metab. 87, 1717-1728.
5. Belt A.R., Baldassare J.J., Molnár M., Romero R. and Hertelendy F. (1999). The nuclear transcription factor NF-kB mediates interleukin- 1,-induced expression of cyclooxygenase-2 in human myometrial cells. Am. J. Obstet. Gyneacol. 181, 359-366.
6. Bonizzi G., Bebien M., Otero D. C., Johnson-Vroom K.E., Cao Y., Vu D., Jegga A.G., Bruce J Aronow B.J. Ghosh G., Rickert R.C. and Karin M. (2004). Activation of IKKa target genes depends on recognition of specific kB binding sites by RelB:p52 dimers. EMBO J. 23, 4202-4210.
7. Bours V., Franzoso G., Azarenko V., Park S., Kanno T., Brown K. and Siebenlist U. (1993). The oncoprotein Bcl-3 directly transactivates through kB motifs via association with DNA-binding p50B homodimers. Cell 72, 729-739.
8. Bugg G.J., Riley M.J. Johnston T.A., Baker P.N. and Taggart M.J. (2006). Hypoxic inhibition of human myometrial contractions in vitro: Implications for the regulation of parturition. Eur. J. Clin. Invest. 36, 133-140.
9. Campbell K.J. and Perkins N.D. (2004). Post-translational modifications of RelA(p65) NF-kB. Biochem. Soc. Trans. 32, 1087-1089.
10. Chapman N.R., Rocha S., Adcock I.M. and Perkins N.D. (2002) NF-κB function in cellular stress and human disease. In: Cell and molecular responses to stress. Vol.3. Elsevier Press. Amsterdam. pp 61-73.
11. Chapman N.R., Europe-Finner G.N. and Robson S.C. (2004). Expression and DNA-binding activity of the nuclear factor kappaB (NF-κB) family in the human myometrium during pregnancy and labour. J. Clin. Endocrinol. Metab. 89, 5683-5693.
12. Chapman N.R., Smyrnias I., Anumba D.O.C., Europe-Finner G.N. and Robson S.C. (2005). Expression of the GTP-binding protein (G·s) is repressed by the nuclear factor kappaB (NF-κB) RelA subunit in human myometrium. Endocrinology 146, 4994-5002.
13. Chen D. and Rothenberg E.V. (1994). Interleukin-2 transcription factors as molecular targets of cAMP inhibition: Delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179, 931-942.
14. Chen F.E. and Ghosh G. (1999). Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 18, 6845-6852.
15. Chen L.F., Mu Y. and Greene W.C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21, 6539-6548.
16. Condon J.C., Jeyasuria P., Faust J.M., Wilson J.W. and Mendelson C.R. (2003). A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc. Natl. Acad. Sci. USA 100, 9518-9523.
17. Condon J.C., Jeyasuria P., Faust J.M. and Mendelson C.R. (2004). Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc. Natl. Acad. Sci. USA 101, 4978-4983.
18. Condon J.C., Hardy D.B., Kovaric K. and Mendelson C.R. (2006). Upregulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol. Endocrinol. 20, 764-775.
19. Dong Y.L., Fang L., Kondapaka S., Gangula P.R., Wimalamansa S.J. and Yallampalli C. (1999). Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J. Clin. Invest. 104, 559-565.
20. Elliot C.L., Allport V.C., Loundon J.A.Z., Wu G.D. and Bennett P.R. (2001). Nuclear factor kappa-B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol. Hum. Reprod. 7, 787-790.
21. Europe-Finner G.N., Phaneuf S., Watson S.P. and López-Bernal A. (1993). Identification and expression of G-proteins in human myometrium: Up-regulation of Gas in pregnancy. Endocrinology 132, 2484-2490.
22. Europe-Finner G.N., Phaneuf S., Tolkovsky A.M., Watson S.P. and López-Bernal A. (1994). Down regulation of G·s in human myometrium in term and preterm labour: a mechanism for parturition. J. Clin. Endocrinol. Metab.. 79, 1835-1839.
23. Europe-Finner G.N., Phaneuf S., Mardon H.J. and López-Bernal A. (1996). Human myometrial Gas-small (with serine) and Gas-large (with serine) messenger ribonucleic acid splice variants promote the increased expression of 46- and 54-kilodalton Gas protein isoforms in pregnancy and their down-regulation during labour. J. Clin. Endocrinol. Metab. 81, 1069-1075.
24. Fraser C.C. (2008). G protein-Coupled Receptor Connectivity to NF-κB in inflammation and cancer. Int. Rev. Immunol. 27, 320-350.
25. Franzoso G., Bours V., Azarenko V., Park S., Tomita-Yamaguchi M., Kanno T., Brown K. and Siebenlist U. (1993). The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select ÎB sites. EMBO J. 12, 3893-3901.
26. Fujita T., Nolan G.P., Liou H.C., Scott M.L. and Baltimore D. (1993). The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7, 1354-1363
27. Fusco A.J., Huang D.B., Miller D., Wang V.Y.F., Vu D. and Ghosh G. (2009). NF-kB p52:RelB heterodimer recognizes two classes of kB sites with two distinct modes. EMBO Rep. 10, 152-159.
28. Gerondakis S., Grossmann M., Nakamura Y., Pohl T. and Grumont R. (1999). Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene 18, 6888-6895.
29. Gill (2000). The socioeconomic impact of preterm delivery. In: The endocrinology of parturition. Basic science and clinical application. Smith R. (ed). Front. Horm. Res. 27, 1-9.
30. Guberman A.S., Scassa M.E., Giono L.E., Varone C.L. and Cánepa E.T. (2003). Inhibitory effect of AP-1 complex on 5-aminolevulinate synthase gene expression through sequestration of cAMP-response element protein (CRE)-binding protein (CBP) Coactivator. J. Biol. Chem. 278, 2317-2326.
31. Gulick T., Chung M.K., Pieper S.J., Lange L.G. and Schreiner G.F. (1989). Interleukin-1 and tumour necrosis factor inhibit cardiac myocyte ß-adrenergic responsiveness. Proc. Natl. Acad. Sci. USA. 86, 6753-6757.
32. Hardy D.B., Janowski B.A., Corey D.R. and Mendelson C.R. (2006). Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol. Endocrinol. 20, 2724-2733.
33. Hoffman A. and Baltimore D. (2006). Circuitry of Nuclear Factor κB signalling. Immunol. Rev. 210, 171-186.
34. Hoffmann A., Leung T.H. and Baltimore D. (2003). Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J. 22, 5530-5539.
35. Horvai A.E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T.M., Rose D.W., Rosenfeld M.G. and Glass C.K. (1997). Nuclear integration of JAK/STAT and Ras/AP-1 signalling by CBP and p300. Proc. Natl. Acad. Sci. USA 94, 1074-1079.
36. qα protein expression and function in human airway smooth muscle cells. Am. J. Physiol. 276 (Lung Cell. Mol. Physiol. 20), L405-L411.
37. α controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc. Natl. Acad. Sci. USA 97, 1014-1019.
38. Huang T.T. and Miyamoto S. (2001). Postrepression activation of NF-κB requires the amino-terminal nuclear export signal specific to IκBα. Mol. Cell. Biol. 21, 4737-4747.
39. uxford T., Huang D.B., Malek, S. and Ghosh G. (1998). The crystal structure of the IκBα /NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95, 759-770.
40. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner E.B.-M., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A. and François Peyron J.F. (1996). Tyrosine phosphorylation of IκBα Activates NF-κB without Proteolytic Degradation of IκBα. Cell 86, 787-798.
41. Jacobs M.D. and Harrison S.C. (1998). Structure of an IκBα /NF-κB Complex. Cell 95, 749-758.
42. Johnson C., Van Antwerp D. and Hope T.J. (1999). An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of Iκα. EMBO J. 18, 6682-6693.
43. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K. and Rosenfeld M.G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
44. Lappas M. and Rice G.E. (2004). Phospholipase-A2 isozymes in pregnancy and parturition. Prostaglandins, Leukotrienes and Essential Fatty Acids 70, 87-100.
45. Lappas M. and Rice G.E. (2007). The Role and Regulation of the Nuclear Factor Kappa B Signalling Pathway in Human Labour. Placenta, 28, 543-556.
46. Lappas M., Permezel M. and Rice G.E. (2003). N-acetyl-cysteine inhibits phospholipids metabolism, proinflammatory cytokine release, protease activity and Nuclear Factor-κB deoxyribonucleic acidbinding activity in human fetal membranes in vitro. J. Clin. Endocrinol. Metab. 88, 1723-1729.
47. Lappas M., Permezel M., Geogiou H.M. and Rice G.E. (2004). Regulation of phospholipase isozymes by Nuclear Factor-κB in human gestational tissues in vitro. J. Clin. Endocrinol. Metab. 89, 2365-2372.
48. Lee Y., Allport V., Sykes A., Lindstrom T., Slater D. and Bennett P.R. (2003). The effects of labour and of interleukin-1 beta upon the expression of nuclear factor kappaB related proteins in human amnion. Mol. Hum. Reprod. 9, 213-218.
49. Leung T.H., Hoffmann A. and Baltimore D. (2004) One nucleotide in a κB site can determine cofactor specificity for NF-κB dimers. Cell 118, 453-464
50. Lindström T.M. and Bennett P.R. (2005). 15-Deoxy-△12,14- Prostaglandin J2 Inhibits Interleukin-1ß-Induced Nuclear Factor-κB in Human Amnion and Myometrial Cells: Mechanisms and Implications. J. Clin. Endocrinol. Metab. 90, 3534-3543.
51. Lindström T.M., Mohan A.R., Johnson M.R. and Bennett P.R. (2008). Histone deacetylase inhibitors exert time-dependent effects on Nuclear Factor-κB but consistently suppress the expression of proinflammatory genes in human myometrial cells. Mol. Pharmacol. 74, 109-121.
52. Long A.A., Chapman N.R., Europe-Finner G.N. and Robson S.C. (2005). Expression and interactions of the transcriptional coregulators CBP/p300 in the human myometrium during pregnancy. J. Soc. Gynaecol. Invest. 12, 92-97.
53. Lumley J. (2003). Defining the problem: the epidemiology of preterm birth. Br. J. Obstet. Gynaecol. 110 (Suppl. 20), 3-7.
54. MacDougall M.W.J., Europe-Finner G.N. and Robson S.C. (2003). Human myometrial quiescence and activation during gestation and parturition involve dramatic changes in expression and activity of particulate type II (RII·) protein kinase A holoenzyme. J. Clin. Endocrinol. Metab. 88, 2194-2205.
55. Mangham L.J., Petrou S., Doyle L.W., Draper E.S. and Marlow N. (2009). The cost of preterm birth throughout childhood in England and Wales. Pediatrics. 123, 312-327.
56. Marienfeld R., May M.J., Berberich I., Serfling E., Ghosh S. and Neumann M. (2003). RelB forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278, 19852-19860.
57. Marlow N., Wolke D., Bracewell M.A. and Samara M. (for the EPICure Study Group) (2005). Neurologic and developmental disability at six years of age after extremely preterm birth. New. Engl. J. Med. 352, 9-19.
58. Maternity Statistic, England, Department of Health May 2003-2004.
59. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F. and Munson M.L. (2005). Births: Final Data for 2003. National Vital Statistics Reports 54: (2) National Centre for Health Statistics. Hyattsville. Maryland.
60. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., Rinn J.L., Nelson F.K., Miller P., Gerstein M., Weissman S. and Snyder M. (2003). Distribution of NF-kappaBbinding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA. 100, 12247-12252.
61. Mohan A.R., Sooranna S.R., Lindstrom T.M., Johnson M.R. and Bennett P.R. (2007). The effect of mechanical stretch on cyclooxygenase type 2 expression and activator protein-1 and nuclear factor-kappaB activity in human amnion cells. Endocrinology 148, 1850-1857.
62. Mukhopadhyay A., Manna S.K. and Aggarwal B.B. (2000). Pervanadate-induced Nuclear Factor-κB activation requires tyrosine phosphorylation and degradation of IkBa. J. Biol. Chem. 275, 8549-8555.
63. Natoli G., Saccani S., Bosisio D. and Marazzi I. (2005). Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6, 439-445.
64. Neumann M., Grieshammer T., Chuvpiol S., Kneitz B., Lohoff M., Schimpl A., Franza B.R. Jr. and Serfling E. (1995). RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14, 1991-2004.
65. Oei S.G. (2006). Calcium channel blockers for tocolysis: A review of their role and safety following reports of serious adverse events. Eur. J. Obstet. Gynaecol. Reprod. Biol. 126, 137-145.
66. Parry G.C.N. and Mackman N. (1997). Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J. Immunol. 159, 5450-5456.
67. Perkins N.D. (1997). Achieving transcriptional specificity with NF-κB. Int. J. Biochem. Cell B. 29, 1433-1448.
68. Perkins N.D. (2007). Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell. Biol. 8, 49-62.
69. Perkins N.D. and Gilmore T.D. (2006). Good Cop, Bad Cop: The Different Faces of NF-κB. Cell Death Diff. 13, 759-772.
70. Phaneuf S., Europe-Finner G.N., Varney M., Mackenzie I.E., Watson S.P. and López-Bernal A. (1993). Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins. J. Endocrinol. 136, 497-509.
71. Perkins N.D., Schmid R.M., Duckett C.S., Leung K., Rice N.R. and Nabel G.J. (1992). Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA 89, 1529-1533.
72. Phillips R.J., Bailey J., Robson S.C. and Europe-Finner G.N. (2002). The differential expression of the adenylyl cyclase-stimulatory GTPbinding protein Gas in the human myometrium during pregnancy and labour involves transcriptional regulation by cyclic AMP and binding of phosphorylated nuclear proteins to multiple GC boxes within the promoter. J. Clin. Endocrinol. Metab. 87, 5675-5685.
73. Phillips R.J., Tyson-Capper (née Pollard) A.J., Bailey J., Robson S.C. and Europe-Finner G.N. (2005). Regulation of expression of the chorionic gonadotropin/luteinizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases. J. Clin. Endocrinol. Metab. 90, 3479-3490.
74. Pomerantz J.L. and Baltimore D. (2002). Two pathways to NF-κB. Mol. Cell. 10, 693-701.
75. Poppers D.M., Schwenger P. and Vilãek J. (2000). Persistent tumor necrosis factor signaling in normal human fibroblasts prevents the complete resynthesis of IkBa. J. Biol. Chem. 275, 29587-29593.
76. Reynaert N.L., Ckless K., Korn S.H., Vos N., Guala A.S., Wouters E.F.M., van der Vliet A. and Janssen-Heininger Y.M.W. (2004). Nitric oxide represses inhibitory kB kinase through S-nitrosylation Proc. Natl. Acad. Sci. USA 101, 8954-18950
77. Rocha S. (2007). Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem. Sci. 32, 389-397.
78. Saccani S., Pantano S. and Natoli, G. (2003). Modulation of NF-κB activity by exchange of dimers. Mol. Cell 11, 1563-1574.
79. Sadowsky D.W., Novy M.J., Witkin S.S. and Gravett M.G. (2003). Dexamethasone or interleukin-10 blocks interleukin-1,-induced uterine contractions in pregnant rhesus monkeys. Am. J. Obstet. Gynaecol. 188, 252-263.
80. 2 production. J. Immunol. 170, 158-166.
81. Schmitz M.L., Bacher S. and Kracht M. (2001). IκB-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem. Sci. 26, 186-190.
82. Schottelius A.J.G., Mayo M.W., Sartor R.B. and Baldwin A.S. (1999). Interleukin-10 signalling blocks inhibitor of κB kinase activity and Nuclear Factor kB DNA binding. J. Biol. Chem. 274, 31868-31874.
83. Schoonbroodt S., Ferreira V., Best-Belpomme M., Boelaert J.R., Legrand-Poels S., Korner M. and Piette J. (2000). Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IκBα in NF-κB activation by an oxidative stress. J. Immunol. 164, 4292-4300.
84. Schreiber J., Jenner, R.G., Murray H.L., Gerber G.K., Gifford D.K. and Young R.A. (2006). Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 103, 5899-5904.
85. Senftleben U., Cao Y., Xiao G., Greten F.R., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C. and Karin M. (2001). Activation by IKKα of a second, evolutionary conserved, NF-kB signalling pathway. Science 293, 1495-1499.
86. Smith C.L., Oñate S.A., Tsai M.J., O'Malley B.W. (1996). CREB binding protein acts synergistically with steroid receptor co-activator-1 to enhance steroid receptor-dependant transcription. Proc. Natl. Acad. Sci. USA 93, 8884-8888.
87. Smith R. (2007). Mechanisms of disease: Parturition. N. Eng. J. Med. 356, 271-283
88. Soloff M.S., Cook D.L. Jr, Jeng Y-J. and Anderson G.D. (2004). In situ analysis of interleukin-1 induced transcription of cox-2 and il-8 in cultured human myometrial cells. Endocrinology 145, 1248-1254.
89. Soloff M.S., Izban. M.G., Cook Jr D.L., Jeng Y.-J. and Mifflin R.C. (2006). Interleukin-1-induced NF-kappaB recruitment to the oxytocin receptor gene inhibits RNA polymerase II-promoter interactions in cultured human myometrial cells. Mol. Hum. Reprod. 12, 619-624.
90. Stjernholm-Vladic Y., Stygar D., Mansson C., Masironi B., Akerberg S., Wang H., Ekman-Ordeberg G. and Sahlin L. (2004). Factors involved in the inflammatory events of cervical ripening in humans. Rep. Biol. Endocrinol. 2, 74; available from www.rbej.com/content/2/1/74.
91. Taggart M.J. and Wray S. (1998). Hypoxia and smooth muscle function: key regulatory events during metabolic stress. J. Physiol. 509, 315-325.
92. Terzidou V., Lee Y., Lindström T., Johnson M., Thornton S. and Bennett P.R. (2006). Regulation of the Human Oxytocin Receptor by Nuclear Factor-κB and CCAAT/Enhancer-Binding Protein-κB. J. Clin. Endocrinol. Metab. 91, 2317-2326.
93. VAN Uden P., Kenneth N.S. and Rocha S. (2008). Regulation of Hypoxia-Inducible Factor-1α by NF-κB. Biochem. J. 412, 477-484.
94. Wadgaonkar R., Phelps K.M., Haque Z., Williams A.J., Silverman E.S. and Collins T. (1999). CREB-binding protein is a nuclear integrator of nuclear factor-kB and p53 signalling. J. Biol. Chem. 274, 1879-1882.
95. Waltner-Law M., Daniels M.C., Sutherland C. and Granner D.K. (2000). NF-κB inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene. J. Biol. Chem. 275, 31847-31856.
96. Warren A.Y., Matharoo-Ball B., Shaw R.W. and Khan R. (2005). Hydrogen peroxide and superoxide anion modulate pregnant human myometrial contractility. Reproduction 130, 539-544.
97. Webster G.A. and Perkins N.D. (1999). Transcriptional cross talk between NF-kB and p53. Mol. Cell. Biol. 19, 3485-3495.
98. Wray S. (1990). The effects of metabolic inhibition on uterine metabolism and intracellular pH in the rat. J. Physiol. 423, 411-423.
99. Yan X., Sun M. and Gibb W. (2002a). Localisation of Nuclear Factor-κB (NF-κB ) and Inhibitory Factor-κB (IκB) in human fetal membranes and deciduas at term and preterm delivery. Placenta 23, 288-293.
100. Yan X., Xiao C. W., Sun M., Tsang B.K. and Gibb W. (2002b). Nuclear factor kappaB activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1,. Biol. Reprod. 66, 1667-1671.
101. Ye R.D. (2001). Regulation of Nuclear Factor-κB activation by Gprotein-coupled receptors. J. Leuk. Biol. 70, 839-848.
102. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P. and Ghosh S. (1997). The transcriptional activity of NF-κB is regulated by the IÎBassociated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413-424.
103. Zhong H., Voll R.E. and Ghosh S. (1998). Phosphorylation of NF-κB p65 PKA stimulates transcriptional activity by promoting a novel bivalent interaction with coactivator CBP/p300. Mol. Cell 1, 661-671.
104. Zuo J. Lei Z.M. And Rao Ch.V. (1994). Human myometrial chorionic gonadotropin/luteinizing hormone receptors in preterm and term deliveries. J. Clin. Endocrinol. Metab. 79, 907-911.